By Dr Christina Signorelli

Conference Papers

Elias J; Mcloone J; Signorelli C; Liang S; Mckay S; Mazariego C; Wakefield C; Cohn R; Alchin J; Taylor N, 2025, 'Integrating Paediatric Cancer Survivorship Care Plans Into Primary Care: A Qualitative Study of Practitioners' Experiences', in PEDIATRIC BLOOD & CANCER, WILEY, pp. S928 - S929

Bidstrup P; Signorelli C; Estape T, 2025, 'Scoping Review on the Implementation of Psychosocial Interventions in Cancer Survivorship', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY

Lucchetti J; Angotti L; Cortellini A; Basso M; Polito M; Zoratto F; Di Giacomo E; Calegari M; Lo Prinzi F; Gemma D; Signorelli C; Veroli M; Anghelone A; Muscio LG; Di Cocco B; Trombetta G; Guerriero S; Schietroma F; Vincenzi B; Tonini G, 2023, 'Aflibercept-based and bevacizumab-based second-line regimens in patients with RAS mutant metastatic colorectal cancer: Propensity score weighted-analysis from a multicenter cohort', in ANNALS OF ONCOLOGY, ELSEVIER, SPAIN, Barcelona, pp. S99 - S99, presented at 25th World Congress on Gastrointestinal Cancer, SPAIN, Barcelona, 28 June 2023 - 01 July 2023, http://dx.doi.org/10.1016/j.annonc.2023.04.292

Signorelli C; Calegari M; Basso M; Anghelone A; Lucchetti J; Minelli A; Angotti L; Zurlo I; Schirripa M; Chilelli M; Morelli C; Dell'Aquila E; Cosimati A; Gemma D; Ribelli M; Corsi D; Arrivi G; Zoratto F; Morandi M; Santamaria F; Saltarelli R; Ruggeri E, 2023, 'Influence of age on disease control rate of patients treated with regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A multicenter retrospective real-world study', in ANNALS OF ONCOLOGY, ELSEVIER, SPAIN, Barcelona, pp. S85 - S85, presented at 25th World Congress on Gastrointestinal Cancer, SPAIN, Barcelona, 28 June 2023 - 01 July 2023, http://dx.doi.org/10.1016/j.annonc.2023.04.251

McLoone J; Hamayun M; Nagabushan S; Signorelli C; Wakefield C; Johnston K; Bell R; Cohn R, 2023, 'PEDIATRIC LOW GRADE GLIOMA SURVIVORS' NEED FOR SURVIVORSHIP CARE: 'ENGAGE' A MULTIDISCIPLINARY, E-HEALTH INTERVENTION.', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, DC, Washington, presented at 7th Pediatric Neuro-Oncology Research Conference, DC, Washington, 22 June 2023 - 24 June 2023

Signorelli C; Calegari MA; Basso M; Anghelone A; Lucchetti J; Minelli A; Angotti L; Zurlo IV; Schirripa M; Chilelli MG; Morelli C; Dell'Aquila E; Gemma D; Ribelli M; Arrivi G; Zoratto F; Morandi MG; Santamaria F; Saltarelli R; Ruggeri EM, 2023, '617P Predictive and prognostic impact of primary tumor location on sequential treatment with regorafenib and trifluridine/tipiracil at third line and beyond in metastatic colorectal cancer: A real-world multicenter retrospective analysis', in Annals of Oncology, Elsevier, pp. s442 - s443, http://dx.doi.org/10.1016/j.annonc.2023.09.1808

Angotti L; Lucchetti J; Cortellini A; Basso M; Polito M; Zoratto F; Di Giacomo E; Calegari M; Prinzi FL; Gemma D; Signorelli C; Veroli M; Trombetta G; Guerriero S; Muscio LG; Di Cocco B; Schietroma F; Anghelone A; Vincenzi B; Tonini G, 2023, 'P-249 Aflibercept-based and bevacizumab-based second-line regimens in patients with RAS/BRAF wild type metastatic colorectal cancer: Propensity score weighted-analysis from a multicenter cohort', in Annals of Oncology, Elsevier, pp. s103 - s104, http://dx.doi.org/10.1016/j.annonc.2023.04.305

Trovato G; Valente G; Calegari M; Dell’Aquila E; Anghelone A; Lucchetti J; Schietroma F; Zurlo I; Signorelli C; Morelli C; Zoratto F; Caira G; Spring A; Saltarelli R; Cosimati A; Schirripa M; Santamaria F; Angotti L; Salvatore L; Pozzo C; Basso M; Tortora G, 2023, 'P-360 Efficacy of regorafenib according to extended RAS evaluation: A multicenter retrospective analysis', in Annals of Oncology, Elsevier, pp. s140 - s141, http://dx.doi.org/10.1016/j.annonc.2023.04.416

Caira G; Calegari M; Anghelone A; Lucchetti J; Dell’Aquila E; Signorelli C; Spring A; Saltarelli R; Cosimati A; Zurlo I; Angotti L; Schietroma F; Pozzo C; Chiofalo L; Santamaria F; Morelli C; Zoratto F; Schirripa M; Salvatore L; Basso M; Tortora G, 2023, 'P-368 Efficacacy of trifluridine/tipiracil according to extended RAS evaluation: A multicenter retrospective analysis', in Annals of Oncology, Elsevier, pp. s143, http://dx.doi.org/10.1016/j.annonc.2023.04.424

Signorelli C; Schirripa M; Chilelli MG; Calegari MA; Basso M; Anghelone A; Lucchetti J; Minelli A; Angotti L; Morelli C; Dell'Aquila E; Cosimati A; Gemma D; Ribelli M; Corsi DC; Arrivi G; Zoratto F; Morandi MG; Santamaria F; Saltarelli R; Ruggeri EM, 2022, '398P Effectiveness and safety of regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A real-world multicenter retrospective study with focus on sequential treatment', in Annals of Oncology, Elsevier, pp. s719, http://dx.doi.org/10.1016/j.annonc.2022.07.536

Signorelli C; Chilelli M; Amodio P; Schirripa M; Sperduti I; Santoro R; Ranalli T; Pessina G; Natoni F; Virtuoso A; Berrios JG; Mazzotta M; Nelli F; Fabbri M; Primi F; Marrucci E; Ruggeri E, 2022, 'P-297 Prognostic impact of primary tumor location on synchronous and metachronous colorectal liver metastases: A retrospective monocentric real-life analysis', in Annals of Oncology, Elsevier, pp. s351 - s352, http://dx.doi.org/10.1016/j.annonc.2022.04.386

Wakefield C; Quinn V; Doolan E; Fardell J; Tucker K; Patenaude A; Marshall K; Lock R; Signorelli C; Georgiou G; Cohn R, 2017, 'The use of Murine Models of Chemosensitivity to Anticancer Agents in Childhood Cancer Clinical Care: Survivor, Parent and Community Acceptability and Willingness-to-Pay', in PEDIATRIC BLOOD & CANCER, WILEY, pp. S60 - S61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408978201113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Natoli G; Nelli F; Moscetti L; D'Auria G; Signorelli C; Chilelli MG; Padalino D; Massari A; Ruggeri EM, 2009, '5061 Gemcitabine and carboplatin in heavily pretreated metastatic breast cancer: predictive value of breast cancer subtypes', in European Journal of Cancer Supplements, Elsevier, pp. 279, http://dx.doi.org/10.1016/s1359-6349(09)70953-x

Back to profile page